Why the study?
Does intravenous heparin administration monitored by activated clotting time prevent embolic and bleeding complications in patients with prosthetic heart valves undergoing surgery for intracranial hemorrhage?
Population
4 patients with prosthetic heart valves who suffered intracranial hemorrhage during long-term oral…
Design
Case_series
Authors
Loading...
May support ACT-monitored heparin in select prosthetic valve cases with ICH; leaves open need for prospective trials before practice change.
Does intravenous heparin administration monitored by activated clotting time prevent embolic and bleeding complications in patients with prosthetic heart valves undergoing surgery for intracranial hemorrhage?
Intravenous heparin monitored by activated clotting time appears useful to prevent embolic and bleeding complications during surgical treatment of intracranial hemorrhage in patients with prosthetic heart valves.
Nakagawa et al. (1995) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: